Mechanisms and Therapeutic Strategies for MAFLD Targeting TLR4 Signaling Pathways
Journal of Innate Immunity · 2024 · 16 (1) · 45-55
DOI: 10.1159/000535524 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Innate Immunity, online erschienen am 21.12.2023. Verfasst von Guanghui Ren und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Liver Disease Center of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Dalia…. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Oxidative Stress. Die Arbeit wurde bisher 30-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background: Metabolic-associated fatty liver disease (MAFLD) is one of the most common chronic liver diseases. The underlying pathophysiological mechanisms are intricate and involve various factors. Unfortunately, there is currently a lack of available effective treatment options. Toll-like receptors (TLRs) are a group of pattern-recognition receptors that are responsible for activating the innate immune system. Research has demonstrated that TLR4 plays a pivotal role in the progression of MAFLD by facilitating the pathophysiological mechanisms. Summary: Lipid peroxidation, pro-inflammatory factors, insulin resistance (IR), and dysbiosis of intestinal microbiota are considered as the pathogenic mechanisms of MAFLD. This review summarizes the impact of TLR4 signaling pathways on the progression of MAFLD, specifically in relation to lipid metabolic disorders, IR, oxidative stress, and gut microbiota disorders. Additionally, we emphasize the potential therapeutic approaches for MAFLD that target TLR4 signaling pathways, including the use of plant extracts, traditional Chinese medicines, probiotics, pharmaceuticals such as peroxisome proliferator-activated receptor antagonists and farnesol X agonists, and lifestyle modifications such as dietary changes and exercise also considered. Furthermore, TLR4 signaling pathways have also been linked to the lean MAFLD. Key Messages: TLR4 plays a crucial role in MAFLD by triggering IR, buildup of lipids, imbalance in gut microbiota, oxidative stress, and initiation of immune responses. The mitigation of MAFLD can be accomplished by suppressing the TLR4 signaling pathway. In the future, it could potentially emerge as a therapeutic target for the condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Disease, Liver Disease Center of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, China, 18842664480@163.com.
- Dalian Hospital of Traditional Chinese Medicine, Dalian, China.
- Department of Infectious Disease, Liver Disease Center of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
Zitieren
APA
Ren, G., Bai, C., Yi, S., Cong, Q., & Zhu, Y. (2024). Mechanisms and Therapeutic Strategies for MAFLD Targeting TLR4 Signaling Pathways. Journal of Innate Immunity, 16(1), 45-55. https://doi.org/10.1159/000535524
Vancouver
Ren G, Bai C, Yi S, Cong Q, Zhu Y. Mechanisms and Therapeutic Strategies for MAFLD Targeting TLR4 Signaling Pathways. Journal of Innate Immunity. 2024;16(1):45-55. doi:10.1159/000535524
BibTeX
@article{Ren2024,
author = {Ren, Guanghui and Bai, Changchuan and Yi, Sitong and Cong, Qingwei and Zhu, Ying},
title = {Mechanisms and Therapeutic Strategies for MAFLD Targeting TLR4 Signaling Pathways},
journal = {Journal of Innate Immunity},
year = {2024},
volume = {16},
number = {1},
pages = {45--55},
doi = {10.1159/000535524}
}
EUVIMED